Close Menu

NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal year 2019 first quarter revenues rose 35 percent year over year due to continued effects of the acquisition of C.R. Bard and growth across all three of its business segments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.